Form D · Biotechnology

Selexagen Therapeutics, Inc.

San Diego, CA · CIK 0001507335

Offering snapshot reported Jul 25, 2011 · SEC filing

Reported sold
$597K
Offering amount: $597K
Investors reported
4
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Nov 29, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$299K$597KDec 9, 2010: $497,391.00Dec 9, 2010Jul 25, 2011: $597,387.00Jul 25, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$497,391 → $597,387

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 25, 2011Amendment$597,387$99,996vs Dec 9, 20104SEC filing
Dec 9, 2010Initial$497,391No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-151616

Source: Form D, filed Jul 25, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Scott L. Glenn Director
Patrick O'connor Director, Executive
Lauren G. Otsuki Director, Executive
Randall Woods Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4653 Carmel Mountain Road Suite 308
San Diego, CA, 92130